碳青霉烯类抗生素对重症肺部感染治疗的效果研究

Effect of Carbapenem Antibiotics on Anti-infection Treatment of Severe Pulmonary Infection

研究了重症肺部感染患者采用碳青霉烯类抗生素进行治疗的作用和效果。分组方式为随机数字表法,实验时间在2020年3月—2022年3月期间,实验对象为聊城市茌平区人民医院接收的70例重症肺部感染患者,将其平均分为参照组和观察组,每组入组病人35例,采用不同的治疗方法,分别为头孢哌酮钠舒巴坦钠治疗(参照组),碳青霉烯类抗生素美罗培南治疗(观察组)。将康复指标、满意度、生活质量、治疗效果、炎性因子、肺功能情况作为两组治疗效果的对比指标。两组病人经过碳青霉烯类抗生素和头孢哌酮钠舒巴坦钠方法治疗后,观察组患者各项指标更优(P<0.05)。研究发现对重症肺部感染患者采用碳青霉烯类抗生素能够提高病人的生活质量,并且在治疗效果和症状评分等方面作用相对明显,值得推广。

To study the effect of carbapenem antibiotics in patients with severe pulmonary infection.The grouping method was random number table.The experimental time was from March 2020 to March 2022.The experimental subjects were 70 patients with severe pulmonary infection received by The People’s Hospital of Chiping District.They were equally divided into the reference group and the observation group.Each group included 35 patients.Different treatment methods were used,that is cefoperazone sodium sulbactam sodium treatment(reference group)and carbapenem antibiotic meropenem treatment(observation group).The rehabilitation indicators,satisfaction,quality of life,treatment effect,inflammatory factor s,and pulmonary function were taken as the comparative indicators of the treatment effects of the two groups.After the two groups of patients were treated with carbapenem antibiotics and cefoperazone sodium and sulbactam sodium,the patients in the observation group had significantly better indicators(P<0.05).The use of carbapenem antibiotics in patients with severe pulmonary infection can improve the quality of life of patients,and has a relatively obvious effect in the treatment effect and symptom score,which is worthy of promotion.